Does vitamin D signaling help regulate immune activity and neuroinflammation?

Vitamin D is a biologically active immune regulator, and its signaling may influence CNS inflammatory pathways. For an 83-year-old man with a neurodegenerative condition, avoiding and correcting clinically identified deficiency may be reasonable under usual medical care, but vitamin D should not be viewed as a proven treatment for immune vulnerability or neurodegeneration.

Immune and neuroinflammatory mechanisms

• Calcitriol activates the vitamin D receptor (VDR) in monocytes/macrophages, dendritic cells, T cells, and B cells, regulating antimicrobial peptides, autophagy, cytokine production, and lymphocyte differentiation. Its effect is immunomodulatory—not simply “immune boosting.”
• In cellular and animal CNS models, VDR activation suppresses pro-inflammatory microglial polarization, reducing IL-1β and TNF-α while increasing IL-10. VDR deficiency has been linked to TNF-α/IFN-γ increases, endothelial CXCL10 signaling, blood–brain-barrier disruption, and lymphocyte recruitment.
• Astrocytic and neuronal VDR signaling may also restrain inflammatory activation. These findings support a mechanistic role in neuroinflammation, but direct human evidence of reduced CNS inflammation with supplementation is limited.

Clinical evidence and interpretation

• Lower serum 25(OH)D is consistently associated in cohort meta-analyses with higher incident dementia and Alzheimer disease risk, but this cannot establish causation: reduced mobility, diet, illness severity, adiposity, renal function, and less sunlight exposure can lower vitamin D status.
• No direct cohort or randomized evidence establishes that low vitamin D predicts infections, vaccine responses, inflammatory immune outcomes, or infection-related hospitalization specifically in neurodegenerative disease.
• In 12 respiratory-infection trials totaling 41,552 participants, supplementation showed little or no average benefit (RR 0.99, 95% CI 0.97–1.02); another review estimated RR 0.94 (95% CI 0.87–1.02). A long-term-care high-dose monthly regimen reduced respiratory infections but increased falls.

Bottom line

• Vitamin D signaling clearly regulates immune biology and plausibly modulates neuroinflammation, but low vitamin D as a cause of impaired immune resilience in neurodegenerative disease remains clinically unconfirmed. Correct deficiency for standard clinical indications, while avoiding unsupervised high-dose regimens—especially in frail older adults.